IMFINZI
These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI (durvalumab) injection, for intravenous useInitial U.S. Approval: 2017
8baba4ea-2855-42fa-9bd9-5a7548d4cec3
HUMAN PRESCRIPTION DRUG LABEL
Jun 16, 2023
AstraZeneca Pharmaceuticals LP
DUNS: 054743190
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Durvalumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Durvalumab
Product Details
FDA regulatory identification and product classification information